Clinical Trials

Do you have Narcolepsy?  Suffer from Insomnia? 
Does your adolescent have symptoms of Restless Legs Syndrome?

Restless Legs Syndrome

Clete Kushida, MD, PhD

Purpose: to study the drug, HORIZANT in adolescents with moderate-to-severe Restless Legs Syndrome (RLS)

Payment offered for participation

Time needed from participant:
Option 1 – up to 15 weeks
Option 2 - after completion of Option 1, you may be eligible for roll-over for up to 38 weeks

To qualify, you must:

  • Be between the ages of 13 - 17

Coordinator Contact:
Polina Davidenko (650) 721-7552
pdaviden@stanford.edu

Restless Legs Syndrome

Purpose: to study the relationship between sleep disorders and the bacteria in your gut

Payment offered for participation

Get access to results from microbiome samplings

Requirements: Questionnaires & take-home kits for sampling over span of 1 ½ days

To qualify, you must:

  • Be age 18 or older
  • Diagnosed with either RLS or Insomnia
  • No prior history of autoimmune diagnoses

Coordinator Contact:
Polina Davidenko (650) 721-7552
pdaviden@stanford.edu

All Sleep Disorders

Clete Kushida, MD, PhD
Emmanuel Mignot, MD, PhD

The STAGES – Stanford Technology Analytics and Genomics in Sleep study aims to create a database containing sleep related data on 30,000 sleep clinic patients including genetic and phenotypic data to obtain a better understanding of the genetic architecture of sleep, and to improve detection, treatment and prevention of sleep disorders.

Payment offered for participation

Time needed from participant: study procedures can be completed at overnight sleep study. Participants will be asked to wear a “fitness watch” for 2-4 additional weeks at home, and can then keep it after completing the study.

To qualify, you must:

  • Have a scheduled overnight sleep study at the Stanford Sleep Medicine Center
  • Be age 13 or older

Coordinator Contact:
Kimberly Aralar (650) 721-5489
karalar@stanford.edu

Sleep Quality Study

Seiji Nishino, MD, PhD

Purpose: to study the effect of high rebound mattress toppers on sleep and sleep-related symptoms

Payment offered for participation

Time needed from participant: Have a scheduled overnight sleep study at the Stanford Sleep Medicine Center

To qualify, you must:

  • Be age 18 or older

Coordinator Contact:
Kimberly Aralar (650) 721-5489
karalar@stanford.edu

Sleep and Depression

Clete Kushida, MD, PhD

Purpose: to test the ability of a brainwave measurement device in identification and assisting in the diagnosis of depression 

Payment offered for participation

Time needed from participant: Up to 2 months

To qualify, you must:

  • Be age 30 – 59
  • Have untreated depression -OR- be a healthy volunteer (without depression)

Coordinator Contact:
Polina Davidenko (650) 721-7552
pdaviden@stanford.edu

Sleep and Oxygen Levels

Makoto Kawai, MD, D.Sc.

Purpose: to participate in groundbreaking research examining sleep and measures of brain oxygen levels simultaneously.  

Payment offered for participation

Time needed from participant:

  • Spend 6-8 hours of active participation
  • You will be asked to complete one sleep assessment (polysomnography)

To qualify, you must:

  • Be a healthy individual, 60+ years old
  • Be able to travel to Stanford to complete some questionnaires

Coordinator Contact:
Isabelle Cotto (650) 723-2795
ijoly@Stanford.edu

Narcolepsy with cataplexy

Emmanuel Mignot, MD, PhD

Purpose: to study the drug, JZP-258 in subjects with Narcolepsy with Cataplexy

Payment offered to certain subjects

Time needed from participant: Up to 22 weeks

To qualify, you must:

  • Be between the ages of 18 – 70

Coordinator Contact:
Polina Davidenko (650) 721-7552
pdaviden@stanford.edu

Narcolepsy

Clete Kushida, MD, PhD

Purpose: to study a single nightly formulation drug FT218, for the treatment of Excessive Daytime Sleepiness and Cataplexy in subjects with Narcolepsy

Payment offered for participation

Time needed from participant: Up to 17 weeks

To qualify, you must:

  • Be age 16 or older
  • Have documented evidence of Narcolepsy Type-1 (with Cataplexy)
  • No prior use of Xyrem

Coordinator Contact:
Sarah DeLanda (650) 721-7574
sdelanda@stanford.edu

For more information: https://www.ClinicalTrials.gov

Participant’s right questions, contact: 1-866-680-2906